D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
INSP holding history
Inspire Medical Systems, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INSP overviewAll 13F holders of INSPFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,470,462
- Value
- $65.6M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,470,462 | $65.6M | <0.1% | +281,925+23.7% | Added | Holders |
| Q1 2026 | 1,188,537 | $61.3M | <0.1% | −23,625−1.9% | Reduced | Holders |
| Q4 2025 | 1,212,162 | $111.8M | 0.1% | +853,305+237.8% | Added | Holders |
| Q3 2025 | 358,857 | $26.6M | <0.1% | +344,635+2,423.3% | Added | Holders |
| Q2 2025 | 14,222 | $1.85M | <0.1% | −373−2.6% | Reduced | Holders |
| Q1 2025 | 14,595 | $2.32M | <0.1% | +6,842+88.2% | Added | Holders |
| Q4 2024 | 7,753 | $1.44M | <0.1% | +4,780+160.8% | Added | Holders |
| Q3 2024 | 2,973 | $627.5K | <0.1% | −20,310−87.2% | Reduced | Holders |
| Q2 2024 | 23,283 | $3.12M | <0.1% | −8,205−26.1% | Reduced | Holders |
| Q1 2024 | 31,488 | $6.76M | <0.1% | −153,460−83.0% | Reduced | Holders |
| Q4 2023 | 184,948 | $37.6M | 0.1% | +20,246+12.3% | Added | Holders |
| Q3 2023 | 164,702 | $32.7M | 0.1% | −254,631−60.7% | Reduced | Holders |
| Q2 2023 | 419,333 | $136.1M | 0.2% | +201,915+92.9% | Added | Holders |
| Q1 2023 | 217,418 | $50.9M | 0.1% | +76,715+54.5% | Added | Holders |
| Q4 2022 | 140,703 | $35.4M | 0.1% | +43,904+45.4% | Added | Holders |
| Q3 2022 | 96,799 | $17.2M | <0.1% | −16,265−14.4% | Reduced | Holders |
| Q2 2022 | 113,064 | $20.7M | <0.1% | −111,845−49.7% | Reduced | Holders |
| Q1 2022 | 224,909 | $57.7M | 0.1% | −47,978−17.6% | Reduced | Holders |
| Q4 2021 | 272,887 | $62.8M | 0.1% | −41,159−13.1% | Reduced | Holders |
| Q3 2021 | 314,046 | $73.1M | 0.1% | −30,497−8.9% | Reduced | Holders |
| Q2 2021 | 344,543 | $66.6M | 0.1% | −50,576−12.8% | Reduced | Holders |
| Q1 2021 | 395,119 | $81.8M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.